» Articles » PMID: 35069295

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics

Overview
Specialty Psychiatry
Date 2022 Jan 24
PMID 35069295
Authors
Affiliations
Soon will be listed here.
Abstract

Appalachian Kentucky was at the epicenter of the prescription opioid epidemic in the early 2000's. As we enter the third decade of the epidemic, patterns have begun to emerge as people who use drugs (PWUD) transition from use of opioids to other drugs. The purpose of this analysis was to examine longitudinal changes in methamphetamine use in an ongoing cohort of rural people who use drugs (PWUD) in Appalachian Kentucky. All but five of the cohort participants ( = 503) reported nonmedical prescription opioid use (NMPOU) at baseline and those 498 are included in this longitudinal analysis encompassing eight waves of data (2008-2020). Past 6-month use of methamphetamine was the dependent variable. Given the correlated nature of the data, mixed effects logistic regression was utilized to examine changes in methamphetamine use over time. Significant increases in methamphetamine use were observed over the past decade in this cohort of PWUD, especially in recent years (2017-2020). Prevalence of recent use at baseline and each of the follow-up visits was as follows: 9.4, 5.6, 5.0, 5.4, 8.1, 6.8, 6.9, and 33.1%, respectively ( < 0.001). On the contrary, significant reductions in NMPO and heroin use were observed in the same time period. The odds of methamphetamine use at the most recent visit were 25.8 times greater than at baseline (95% CI: 14.9, 44.6) and 52.6% of those reporting methamphetamine use reported injecting the drug. These results provide further evidence of "twin epidemics" of methamphetamine use among NMPOU. While problematic on several fronts, of particular concern is the lack of effective treatment options for methamphetamine use disorder. As policies around the opioid epidemic continue to evolve, particular attention should be paid to the surge in stimulant use in opioid-endemic areas.

Citing Articles

An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine.

Elswick A, Fallin-Bennett A, Roper K, Batty E, McLouth C, Stoops W Harm Reduct J. 2025; 22(1):7.

PMID: 39825407 PMC: 11740499. DOI: 10.1186/s12954-025-01155-6.


Sociodemographic and Clinical Profiles of Patients With Substance Use Disorders Admitted to a Psychiatric Hospital in Erbil: A Retrospective Study.

Saeed B Cureus. 2025; 16(12):e75483.

PMID: 39791088 PMC: 11717325. DOI: 10.7759/cureus.75483.


Violence Exposure, Mental Distress, Substance Use Behaviors, and Overdose Experiences Among People who Inject Drugs.

Otachi J, Thrasher S, Surratt H J Soc Work Pract Addict. 2024; 24(3):270-282.

PMID: 39474319 PMC: 11521365. DOI: 10.1080/1533256x.2023.2164969.


Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances.

Mixson L, Whitney B, Jenkins W, Stopka T, Korthuis P, Drumright L Subst Use. 2024; 18:29768357241272374.

PMID: 39175912 PMC: 11339740. DOI: 10.1177/29768357241272374.


Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020-2023.

Eger W, Abramovitz D, Bazzi A, Borquez A, Vera C, Harvey-Vera A Drug Alcohol Depend. 2024; 259:111318.

PMID: 38692135 PMC: 11463215. DOI: 10.1016/j.drugalcdep.2024.111318.


References
1.
Eiden C, Ginies P, Nogue E, Damdjy Y, Picot M, Donnadieu-Rigole H . High Prevalence of Misuse of Prescribed Opioid Analgesics in Patients with Chronic Non-Cancer Pain. J Psychoactive Drugs. 2019; 51(4):371-376. DOI: 10.1080/02791072.2019.1621410. View

2.
Fugelstad A, Thiblin I, Johansson L, Agren G, Sidorchuk A . Opioid-related deaths and previous care for drug use and pain relief in Sweden. Drug Alcohol Depend. 2019; 201:253-259. DOI: 10.1016/j.drugalcdep.2019.04.022. View

3.
Spolsky V, Clague J, Murphy D, Vitero S, Dye B, Belin T . Periodontal status of current methamphetamine users. J Am Dent Assoc. 2018; 149(3):174-183. PMC: 5831543. DOI: 10.1016/j.adaj.2017.10.017. View

4.
Wiessing L, Ferri M, Belackova V, Carrieri P, Friedman S, Folch C . Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduct J. 2017; 14(1):19. PMC: 5401609. DOI: 10.1186/s12954-017-0141-6. View

5.
Reddy P, Ng T, Oh E, Moady G, Elkayam U . Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review. J Am Heart Assoc. 2020; 9(11):e016704. PMC: 7428977. DOI: 10.1161/JAHA.120.016704. View